Article references (17 references )


  1. Cappellini MD, Motta I. Anemia in Clinical Practice-Definition and Classification: Does Hemoglobin Change With Aging?. Semin Hematol. 2015 Oct; 52(4):261-9. PubMed | Google Scholar

  2. Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PLoS One. 2014 Jan 2; 9(1):e84943. PubMed | Google Scholar

  3. Strippoli GF, Manno C, Schena FP, Craig JC. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. Cochrane Database Syst Rev. 2003; ( 1):CD003967. PubMed | Google Scholar

  4. Dimkovič N. Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency. Med Pregl. 2001 May-Jun; 54(5-6):235-40. PubMed | Google Scholar

  5. Berns JS. Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed?. Semin Dial. 2005 Jan-Feb; 18(1):22-9. PubMed | Google Scholar

  6. Maurin N. Regarding the optimal hemoglobin target range in renal anemia. Med Klin (Munich. 2008 Sep 15; 103(9):633-7. PubMed | Google Scholar

  7. Agarwal AK. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly. J Am Med Dir Assoc. 2006 Nov; 7(9 ):S7-S12. PubMed | Google Scholar

  8. Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial. 2010 Jun;14(3):240-75. PubMed | Google Scholar

  9. Gianella P, Martin PY, Stucker F. Prise en charge de l'anémie rénale en 2013. Rev Med Suisse. 2013;9: 462-7. PubMed | Google Scholar

  10. Ifudu O, Macey LJ, Friedman EA. Resurgence of blood transfusion therapy in erythropoietin treated hemodialysis patients. ASAIO J. 1995 Jul-Sep; 41(3):426-30. PubMed | Google Scholar

  11. Duclos J, Olea C, Aguirre H, Alvarez MC, Salgado MC. Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view. Rev Med Chil. 1995 Apr; 123(4):451-5. PubMed | Google Scholar

  12. Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL. Am J Kidney Dis. 2013 Nov; 62(5):919-28. PubMed | Google Scholar

  13. Maoujoud O, Ahid S, Cherrah Y. The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients. Int J Nephrol Renovasc Dis. 2016 Feb 24;9:35-43. PubMed | Google Scholar

  14. Bravo Zuñiga JI, Loza Munárriz C, López-Alcalde J. Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in hemodialysis units. Cochrane Database Syst Rev. 2016 Aug 11 ;8:CD006420. PubMed | Google Scholar

  15. Senosy SA, El Shabrawy EM. Hepatitis C virus in patients on regular hemodialysis in Beni-Suef Governorate, Egypt. J Egypt Public Health Assoc. 2016 Jun; 91(2):86-9. PubMed | Google Scholar

  16. Hasanjani Roushan MR, Farokhtabar S, Bayani M, Siadati S. Epidemiological Aspects of Hepatitis B and C and Human Immunodeficiency Viruses Among Hemodialysis Patients in Mazandaran Province, Iran. Nephrourol Mon. 2016 May 2; 8(3):e37878. PubMed | Google Scholar

  17. Tounkara AA, Coulibaly AMS, Diakité ML, Coulibaly N, Sissoko I, Maïga MK. Prévalence de la dysfonction érectile parmi les hémodialysés chroniques du service de Néphrologie et d?hémodialyse du CHU du Point G. Uro?Andro. 2016 Juillet ; Volume 1( N° 6):297-300. PubMed | Google Scholar